SPARC surges despite reporting net loss in Q1

07 Aug 2017 Evaluate

Sun Pharma Advanced Research Company (SPARC) is currently trading at Rs. 387.90, up by 31.60 points or 8.87% from its previous closing of Rs. 356.30 on the BSE.

The scrip opened at Rs. 351.00 and has touched a high and low of Rs. 388.70 and Rs. 345.00 respectively. So far 213690 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 414.80 on 05-Aug-2016 and a 52 week low of Rs. 273.00 on 29-May-2017.

Last one week high and low of the scrip stood at Rs. 388.70 and Rs. 345.00 respectively. The current market cap of the company is Rs. 9430.18 crore.

The promoters holding in the company stood at 66.93%, while Institutions and Non-Institutions held 9.09% and 23.97% respectively.

The company has reported a net loss of Rs 78.84 crore for first quarter ended June 30, 2017 as against a net loss of Rs 36.14 crore for the same quarter in the previous year. However, total income of the company increased marginally by 0.49% at Rs 24.62 crore for Q1FY18 as compared Rs 24.50 crore for the corresponding quarter previous year.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

134.40 -0.05 (-0.04%)
31-Dec-2025 14:35 View Price Chart
Peers
Company Name CMP
Syngene Internation. 649.15
Indegene 520.55
CMS Info Systems 338.80
Sagility 52.23
Smartworks Coworking 475.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×